Simon Quick Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.39M | Buy |
18,911
+55
| +0.3% | +$7.25K | 0.1% | 133 |
|
|
2026
Q1 | $2.63M | Sell |
18,856
-2,800
| -13% | -$392K | 0.12% | 122 |
|
|
2025
Q4 | $2.66M | Buy |
21,656
+4,958
| +30% | +$603K | 0.12% | 115 |
|
|
2025
Q3 | $1.85M | Buy |
16,698
+118
| +0.7% | +$13.4K | 0.08% | 145 |
|
|
2025
Q2 | $1.84M | Buy |
16,580
+7,746
| +88% | +$824K | 0.09% | 132 |
|
|
2025
Q1 | $990K | Buy |
8,834
+2,714
| +44% | +$280K | 0.06% | 172 |
|
|
2024
Q4 | $565K | Buy |
6,120
+1,214
| +25% | +$109K | 0.03% | 227 |
|
|
2024
Q3 | $411K | Buy |
4,906
+1,516
| +45% | +$116K | 0.03% | 266 |
|
|
2024
Q2 | $233K | Buy |
3,390
+343
| +11% | +$22.9K | 0.02% | 336 |
|
|
2024
Q1 | $223K | Buy |
3,047
+128
| +4% | +$9.84K | 0.02% | 371 |
|
|
2023
Q4 | $236K | Sell |
2,919
-1,241
| -30% | -$96.6K | 0.02% | 284 |
|
|
2023
Q3 | $312K | Buy |
4,160
+91
| +2% | +$7K | 0.03% | 227 |
|
|
2023
Q2 | $314K | Buy |
4,069
+403
| +11% | +$32.1K | 0.03% | 201 |
|
|
2023
Q1 | $304K | Buy |
+3,666
| New | +$304K | 0.03% | 207 |
|
|
2022
Q2 | – | Sell |
-2,385
| Closed | -$142K | – | 267 |
|
|
2022
Q1 | $142K | Buy |
2,385
+11
| +0.5% | +$703 | 0.04% | 121 |
|
|
2021
Q4 | $172K | Buy |
2,374
+591
| +33% | +$40.7K | 0.05% | 122 |
|
|
2021
Q3 | $124K | Sell |
1,783
-371
| -17% | -$26.1K | 0.03% | 149 |
|
|
2021
Q2 | $148K | Buy |
2,154
+400
| +23% | +$26.7K | 0.04% | 122 |
|
|
2021
Q1 | $113K | Hold |
1,754
| – | – | 0.03% | 139 |
|
|
2020
Q4 | $102K | Sell |
1,754
-813
| -32% | -$49.1K | 0.03% | 140 |
|
|
2020
Q3 | $162K | Sell |
2,567
-216
| -8% | -$15K | 0.05% | 98 |
|
|
2020
Q2 | $214K | Sell |
2,783
-786
| -22% | -$60.2K | 0.08% | 80 |
|
|
2020
Q1 | $267K | Buy |
3,569
+615
| +21% | +$42.5K | 0.1% | 68 |
|
|
2019
Q4 | $192K | Buy |
2,954
+228
| +8% | +$14.8K | 0.07% | 94 |
|
|
2019
Q3 | $173K | Buy |
2,726
+786
| +41% | +$51.4K | 0.08% | 83 |
|
|
2019
Q2 | $131K | Sell |
1,940
-404
| -17% | -$26.6K | 0.07% | 78 |
|
|
2019
Q1 | $152K | Buy |
2,344
+263
| +13% | +$17.5K | 0.06% | 86 |
|
|
2018
Q4 | $130K | Buy |
2,081
+141
| +7% | +$9.86K | 0.05% | 95 |
|
|
2018
Q3 | $150K | Hold |
1,940
| – | – | 0.06% | 82 |
|
|
2018
Q2 | $137K | Sell |
1,940
-800
| -29% | -$56.5K | 0.06% | 99 |
|
|
2018
Q1 | $207K | Buy |
2,740
+393
| +17% | +$31.2K | 0.09% | 77 |
|
|
2017
Q4 | $197K | Sell |
2,347
-398
| -14% | -$30.2K | 0.09% | 99 |
|
|
2017
Q3 | $222K | Buy |
2,745
+600
| +28% | +$45.9K | 0.08% | 119 |
|
|
2017
Q2 | $152K | Hold |
2,145
| – | – | 0.09% | 76 |
|
|
2017
Q1 | $146K | Sell |
2,145
-11,500
| -84% | -$809K | 0.09% | 101 |
|
|
2016
Q4 | $977K | Buy |
+13,645
| New | +$1.01M | 0.73% | 23 |
|
Other funds holding GILD
Simon Quick Advisors's GILD Position: Q2 2026 in Review
Simon Quick Advisors increased its Gilead Sciences (GILD) stake by 0.29% in Q2 2026, buying an estimated $7.25K and bringing the position to 18,911 shares worth $2.39M. The position accounts for 0.1% of the portfolio, ranked #133.
Simon Quick Advisors first reported a position in GILD in Q4 2016 and has held it in 36 quarters since. The position peaked at $2.66M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Simon Quick Advisors held 18,911 shares of Gilead Sciences worth $2.39M as of Q2 2026.
- Simon Quick Advisors bought 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
- Gilead Sciences made up 0.1% of Simon Quick Advisors's portfolio in Q2 2026, its #133 holding.
- Simon Quick Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 36 quarters since.
- Simon Quick Advisors's Gilead Sciences position peaked at $2.66M in Q4 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.